This page shows the latest Fetcroja news and features for those working in and with pharma, biotech and healthcare.
The antibiotic Fetcroja, along with Zavicefta, will be made available as an option to help address antimicrobial resistance. ... The deal comes after the National Institute for Health and Care Excellence’s (NICE) draft guidance recommending Fetcroja,
Fetcroja (cefiderocol). ... Fetcroja can be used to treat urinary tract infections, including kidney infections, and Zavicefta can be used to treat patients with pneumonia and sepsis.
The antibiotic treats infections caused by aerobic Gram-negative bacteria. Shionogi’s novel antibiotic Fetcroja has been selected for inclusion in a pilot subscription reimbursement scheme, launched by the UK’s ... Fetcroja was launched in the UK in
The second study, CREDIBLE-CR, evaluated Fetcroja as a treatment for a diverse range of serious Carbapenem-resistant (CR) infections. ... Fetcroja launched in the UK in September, launching as a treatment of infections caused by aerobic Gram-negative
Novel antibiotic is indicated for use against Gram-negative bacterial infections. Shionogi’s new antibiotic Fetcroja is now available for use in the UK for the treatment of infections caused by ... The launch of Shionogi's Fetcroja (cefiderocol) in the
The CHMP recommended a marketing authorisation of Japanese pharma company Shionogi’s antimicrobial drug Fetcroja (cefiderocol) for the treatment of infections caused by Gram-negative organisms in adults with limited treatment ... options. According to
More from news
Approximately 4 fully matching, plus 2 partially matching documents found.
Hamell is a full-service agency with a clear focus on delivering evidence-based, sustained behaviour change. So, whether you are looking...